{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:35:13Z","timestamp":1781710513327,"version":"3.54.5"},"reference-count":67,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"JSPS KAKENHI","doi-asserted-by":"publisher","award":["JP25K02256"],"award-info":[{"award-number":["JP25K02256"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"JSPS KAKENHI","doi-asserted-by":"publisher","award":["JP24KK0152"],"award-info":[{"award-number":["JP24KK0152"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"JSPS KAKENHI","doi-asserted-by":"publisher","award":["JP25K18443"],"award-info":[{"award-number":["JP25K18443"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tokyo Metropolitan Government Advanced Research","award":["R3-2"],"award-info":[{"award-number":["R3-2"]}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>KRAS is one of the most frequently mutated genes in all human cancers, and its oncogenic mutation hotspots are glycine 12 (G12), glycine 13 (G13), glutamine 61 (Q61) and alanine 146 (A146). Among these hotspot mutations, A146 substitution mutations (A146X) occur relatively infrequently, except for haematopoietic and lymphoid cancers, suggesting that A146X causes intrinsically distinct KRAS signalling compared to other KRAS oncogenic alleles. However, due to the absence of model A146X cell lines derived from haematopoietic sources, the cellular mechanisms that cause the differences between KRAS.A146X and other common KRAS mutants, such as KRAS.G12X, remain largely unexplored. In this study, we developed a set of isogenic model haematopoietic cell lines expressing KRAS.A146T, KRAS.G12V and KRAS.G12G (non-mutated) from the endogenous locus by genetically modifying the human lymphoblastoid TK6 cell line. We found that TK6 cells carrying KRASA146T\/+ or KRASG12V\/+ exhibited increased replication stress compared to KRAS wild-type cells. Strikingly, KRASA146T\/+ cells strongly rely on PrimPol for maintaining cellular survival upon replication stress. In contrast, KRASG12V\/+ cells exhibited hypersensitivity to inhibitors for the ATR-Chk1 checkpoint signalling axis and to nucleoside analogues commonly used to treat cancers and viral infections. Our findings demonstrate that the endogenously expressed oncogenic KRAS mutations exacerbate the replication stress and reveal KRAS allele-specific replication phenotypes, facilitating the development of effective chemotherapies tailored to specific oncogenic KRAS mutation alleles and types of cancer. Moreover, our study offers valuable model cell lines for investigating mechanisms underlying replication vulnerability in cancers harbouring oncogenic KRAS mutations.<\/jats:p>","DOI":"10.3390\/biom16020204","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T15:04:46Z","timestamp":1769612686000},"page":"204","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Generation of Human Haematopoietic Model Cell Lines Revealed Distinct Replication Stress Tolerance Between Two Oncogenic KRAS Mutations, G12V and A146T"],"prefix":"10.3390","volume":"16","author":[{"given":"Mone","family":"Okuda","sequence":"first","affiliation":[{"name":"Department of Chemistry, Graduate School of Science, Tokyo Metropolitan University, Minamiosawa 1-1, Hachioji-shi 192-0397, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6527-6329","authenticated-orcid":false,"given":"Ryotaro","family":"Kawasumi","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Graduate School of Science, Tokyo Metropolitan University, Minamiosawa 1-1, Hachioji-shi 192-0397, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2905-3603","authenticated-orcid":false,"given":"Kayoko","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Division of Molecular and Cell Biology, University of Leicester, Leicester LE1 7RH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1676-979X","authenticated-orcid":false,"given":"Kouji","family":"Hirota","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Graduate School of Science, Tokyo Metropolitan University, Minamiosawa 1-1, Hachioji-shi 192-0397, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e31605","DOI":"10.1002\/pbc.31605","article-title":"RAS Pathway Mutations and Therapeutics in Vascular Anomalies","volume":"72","author":"Alharbi","year":"2025","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.semcancer.2018.01.016","article-title":"Targeting the RAS-dependent chemoresistance: The Warburg connection","volume":"54","author":"Aguilera","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1515\/hsz-2014-0257","article-title":"Ras activation revisited: Role of GEF and GAP systems","volume":"396","author":"Hennig","year":"2015","journal-title":"Biol. Chem."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Gimple, R.C., and Wang, X. (2019). RAS: Striking at the Core of the Oncogenic Circuitry. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.00965"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Mu\u00f1oz-Maldonado, C., Zimmer, Y., and Medov\u00e1, M. (2019). A Comparative Analysis of Individual RAS Mutations in Cancer Biology. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.01088"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1182\/blood.V94.9.2971","article-title":"Ras proteins: Recent advances and new functions","volume":"94","author":"Rebollo","year":"1999","journal-title":"Blood"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"19925","DOI":"10.1074\/jbc.273.32.19925","article-title":"Increasing complexity of the Ras signaling pathway","volume":"273","author":"Vojtek","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc969","article-title":"Targeting RAS signalling pathways in cancer therapy","volume":"3","author":"Downward","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"ref_9","first-page":"5738","article-title":"Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung","volume":"48","author":"Rodenhuis","year":"1988","journal-title":"Cancer Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"7773","DOI":"10.1093\/nar\/16.16.7773","article-title":"KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas","volume":"16","author":"Smit","year":"1988","journal-title":"Nucleic Acids Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5704","DOI":"10.1073\/pnas.81.18.5704","article-title":"Intrinsic GTPase activity distinguishes normal and oncogenic ras p21 molecules","volume":"81","author":"Gibbs","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1158\/1541-7786.MCR-15-0203","article-title":"Biochemical and Structural Analysis of Common Cancer-Associated KRAS Mutations","volume":"13","author":"Hunter","year":"2015","journal-title":"Mol. Cancer Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1158\/2159-8290.CD-18-1220","article-title":"Tissue-Specific Oncogenic Activity of KRAS(A146T)","volume":"9","author":"Poulin","year":"2019","journal-title":"Cancer Discov."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"10505","DOI":"10.1158\/0008-5472.CAN-06-2351","article-title":"Ras induces chromosome instability and abrogation of the DNA damage response","volume":"66","author":"Abulaiti","year":"2006","journal-title":"Cancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1158\/2159-8290.CD-17-1461","article-title":"Mechanisms of Oncogene-Induced Replication Stress: Jigsaw Falling into Place","volume":"8","author":"Kotsantis","year":"2018","journal-title":"Cancer Discov."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"T\u00e9cher, H., Kemiha, S., Aobuli, X., and Kolinjivadi, A.M. (2024). Oncogenic RAS in Cancers from the DNA Replication Stress and Senescence Perspective. Cancers, 16.","DOI":"10.3390\/cancers16233993"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1038\/s41467-023-40578-2","article-title":"An ATR-PrimPol pathway confers tolerance to oncogenic KRAS-induced and heterochromatin-associated replication stress","volume":"14","author":"Igarashi","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nrc3106","article-title":"RAS oncogenes: Weaving a tumorigenic web","volume":"11","author":"Grabocka","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"8468","DOI":"10.1158\/0008-5472.CAN-07-1126","article-title":"Knock-in of oncogenic Kras does not transform mouse somatic cells but triggers a transcriptional response that classifies human cancers","volume":"67","author":"Arena","year":"2007","journal-title":"Cancer Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1535-6108(03)00191-0","article-title":"Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context","volume":"4","author":"Guerra","year":"2003","journal-title":"Cancer Cell"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e75715","DOI":"10.7554\/eLife.75715","article-title":"Genetically manipulating endogenous Kras levels and oncogenic mutations in vivo influences tissue patterning of murine tumorigenesis","volume":"11","author":"Pershing","year":"2022","journal-title":"eLife"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0076-6879(05)07053-9","article-title":"Physiological analysis of oncogenic K-ras","volume":"407","author":"Tuveson","year":"2006","journal-title":"Methods Enzymol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"107409","DOI":"10.1016\/j.jbc.2024.107409","article-title":"Endogenous oncogenic KRAS expression increases cell proliferation and motility in near-diploid hTERT RPE-1 cells","volume":"300","author":"Hindul","year":"2024","journal-title":"J. Biol. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mrgentox.2016.08.001","article-title":"Standardized cell sources and recommendations for good cell culture practices in genotoxicity testing","volume":"809","author":"Lorge","year":"2016","journal-title":"Mutat. Res. Genet. Toxicol. Environ. Mutagen."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/em.20113","article-title":"Generation of loss of heterozygosity and its dependency on p53 status in human lymphoblastoid cells","volume":"45","author":"Honma","year":"2005","journal-title":"Environ. Mol. Mutagen."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1258096","DOI":"10.1126\/science.1258096","article-title":"Genome editing. The new frontier of genome engineering with CRISPR-Cas9","volume":"346","author":"Doudna","year":"2014","journal-title":"Science"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.32607\/20758251-2014-6-3-19-40","article-title":"TALEN and CRISPR\/Cas Genome Editing Systems: Tools of Discovery","volume":"6","author":"Nemudryi","year":"2014","journal-title":"Acta Nat."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.molcel.2013.10.035","article-title":"PrimPol bypasses UV photoproducts during eukaryotic chromosomal DNA replication","volume":"52","author":"Bianchi","year":"2013","journal-title":"Mol. Cell"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Guilliam, T.A., and Doherty, A.J. (2017). PrimPol-Prime Time to Reprime. Genes, 8.","DOI":"10.3390\/genes8010020"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1080\/15384101.2016.1191711","article-title":"Repriming by PrimPol is critical for DNA replication restart downstream of lesions and chain-terminating nucleosides","volume":"15","author":"Kobayashi","year":"2016","journal-title":"Cell Cycle"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"103787","DOI":"10.1016\/j.dnarep.2024.103787","article-title":"PrimPol-mediated repriming elicits gap-filling by template switching and promotes cellular tolerance to cidofovir","volume":"145","author":"Washif","year":"2025","journal-title":"DNA Repair"},{"key":"ref_32","first-page":"4417","article-title":"Evaluation of the antitumor activity of gemcitabine (2\u2032,2\u2032-difluoro-2\u2032-deoxycytidine)","volume":"50","author":"Hertel","year":"1990","journal-title":"Cancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"33457","DOI":"10.18632\/oncotarget.16508","article-title":"The dominant role of proofreading exonuclease activity of replicative polymerase \u03b5 in cellular tolerance to cytarabine (Ara-C)","volume":"8","author":"Tsuda","year":"2017","journal-title":"Oncotarget"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"103503","DOI":"10.1016\/j.dnarep.2023.103503","article-title":"CTF18-RFC contributes to cellular tolerance against chain-terminating nucleoside analogs (CTNAs) in cooperation with proofreading exonuclease activity of DNA polymerase \u03b5","volume":"127","author":"Washif","year":"2023","journal-title":"DNA Repair"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Washif, M., Kawasumi, R., and Hirota, K. (2024). REV3 promotes cellular tolerance to 5-fluorodeoxyuridine by activating translesion DNA synthesis and intra-S checkpoint. PLoS Genet., 20.","DOI":"10.1371\/journal.pgen.1011341"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/gtc.12929","article-title":"XRCC1 counteracts poly(ADP ribose)polymerase (PARP) poisons, olaparib and talazoparib, and a clinical alkylating agent, temozolomide, by promoting the removal of trapped PARP1 from broken DNA","volume":"27","author":"Hirota","year":"2022","journal-title":"Genes Cells"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Inomata, Y., Abe, T., Tsuda, M., Takeda, S., and Hirota, K. (2021). Division of labor of Y-family polymerases in translesion-DNA synthesis for distinct types of DNA damage. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0252587"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1093\/nar\/gkv023","article-title":"The POLD3 subunit of DNA polymerase \u03b4 can promote translesion synthesis independently of DNA polymerase \u03b6","volume":"43","author":"Hirota","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"ref_39","first-page":"10","article-title":"Using the Student\u2019s t-test with extremely small sample sizes","volume":"18","year":"2013","journal-title":"Pract. Assess. Res. Eval."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/1097-0142(196809)22:3<517::AID-CNCR2820220305>3.0.CO;2-A","article-title":"Human lymphoblastoid lines from lymph node and spleen","volume":"22","author":"Levy","year":"1968","journal-title":"Cancer"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"503236","DOI":"10.1016\/j.mrgentox.2020.503236","article-title":"TK6 genome profile compared with WIL2-NS: Reference data to improve the reproducibility of genotoxicity studies","volume":"858\u2013860","author":"Kasai","year":"2020","journal-title":"Mutat. Res. Genet. Toxicol. Environ. Mutagen."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10120-024-01468-8","article-title":"Biological and targeting differences between the rare KRAS A146T and canonical KRAS mutants in gastric cancer models","volume":"27","author":"Puliga","year":"2024","journal-title":"Gastric Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"16037","DOI":"10.1016\/S0021-9258(18)66672-4","article-title":"Changes of deoxyribonucleoside triphosphate pools induced by hydroxyurea and their relation to DNA synthesis","volume":"261","author":"Bianchi","year":"1986","journal-title":"J. Biol. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41419-020-2704-9","article-title":"Reduced replication origin licensing selectively kills KRAS-mutant colorectal cancer cells via mitotic catastrophe","volume":"11","author":"Gastl","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/275458a0","article-title":"Aphidicolin prevents mitotic cell division by interfering with the activity of DNA polymerase-alpha","volume":"275","author":"Ikegami","year":"1978","journal-title":"Nature"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.molcel.2010.01.021","article-title":"Hydroxyurea-stalled replication forks become progressively inactivated and require two different RAD51-mediated pathways for restart and repair","volume":"37","author":"Petermann","year":"2010","journal-title":"Mol. Cell"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.4161\/cc.6.22.4932","article-title":"The mammalian DNA replication elongation checkpoint: Implication of Chk1 and relationship with origin firing as determined by single DNA molecule and single cell analyses","volume":"6","author":"Conti","year":"2007","journal-title":"Cell Cycle"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Jo, U., Murai, Y., Takebe, N., Thomas, A., and Pommier, Y. (2021). Precision Oncology with Drugs Targeting the Replication Stress, ATR, and Schlafen 11. Cancers, 13.","DOI":"10.3390\/cancers13184601"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/bjc.2012.265","article-title":"Targeting radiation-resistant hypoxic tumour cells through ATR inhibition","volume":"107","author":"Pires","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"5600","DOI":"10.1074\/jbc.275.8.5600","article-title":"The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01","volume":"275","author":"Graves","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1158\/1535-7163.MCT-09-0519","article-title":"Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion","volume":"8","author":"Golding","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Geraghty, R.J., Aliota, M.T., and Bonnac, L.F. (2021). Broad-Spectrum Antiviral Strategies and Nucleoside Analogues. Viruses, 13.","DOI":"10.3390\/v13040667"},{"key":"ref_53","first-page":"197","article-title":"Ara-C: Cellular and molecular pharmacology","volume":"72","author":"Grant","year":"1998","journal-title":"Adv. Cancer Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"9063","DOI":"10.1038\/sj.onc.1207229","article-title":"Mechanisms of apoptosis induction by nucleoside analogs","volume":"22","author":"Sampath","year":"2003","journal-title":"Oncogene"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1245\/s10434-023-13353-2","article-title":"FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analysis and Systematic Review","volume":"30","author":"Eshmuminov","year":"2023","journal-title":"Ann. Surg. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e2350756","DOI":"10.1001\/jamanetworkopen.2023.50756","article-title":"NALIRIFOX, FOLFIRINOX, and Gemcitabine with Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis","volume":"7","author":"Nichetti","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/gtc.13155","article-title":"RAD18- and BRCA1-dependent pathways promote cellular tolerance to the nucleoside analog ganciclovir","volume":"29","author":"Ahmad","year":"2024","journal-title":"Genes Cells"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4419-7185-2_17","article-title":"Antiviral therapy of CMV disease in children","volume":"697","author":"Sharland","year":"2011","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nature05327","article-title":"Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication","volume":"444","author":"Fumagalli","year":"2006","journal-title":"Nature"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bpc.2016.11.008","article-title":"Mechanisms of oncogene-induced genomic instability","volume":"225","author":"Graziano","year":"2017","journal-title":"Biophys. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Koundrioukoff, S., Carignon, S., T\u00e9cher, H., Letessier, A., Brison, O., and Debatisse, M. (2013). Stepwise activation of the ATR signaling pathway upon increasing replication stress impacts fragile site integrity. PLoS Genet., 9.","DOI":"10.1371\/journal.pgen.1003643"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1126\/science.1140735","article-title":"An oncogene-induced DNA damage model for cancer development","volume":"319","author":"Halazonetis","year":"2008","journal-title":"Science"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1093\/nar\/gkab176","article-title":"Repriming DNA synthesis: An intrinsic restart pathway that maintains efficient genome replication","volume":"49","author":"Bainbridge","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"102652","DOI":"10.1016\/j.sbi.2023.102652","article-title":"Mechanism of primer synthesis by Primase-Polymerases","volume":"82","author":"Zabrady","year":"2023","journal-title":"Curr. Opin. Struct. Biol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.1073\/pnas.1218173110","article-title":"NMR-based functional profiling of RASopathies and oncogenic RAS mutations","volume":"110","author":"Smith","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41392-021-00780-4","article-title":"KRAS mutation: From undruggable to druggable in cancer","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/s41591-024-02903-0","article-title":"Targeting KRAS in cancer","volume":"30","author":"Singhal","year":"2024","journal-title":"Nat. Med."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/2\/204\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T05:22:43Z","timestamp":1769750563000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/2\/204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":67,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["biom16020204"],"URL":"https:\/\/doi.org\/10.3390\/biom16020204","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]}}}